1991
DOI: 10.1016/0006-8993(91)90095-d
|View full text |Cite
|
Sign up to set email alerts
|

DNQX blockade of amphetamine behavioral sensitization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
71
0
1

Year Published

1993
1993
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 162 publications
(79 citation statements)
references
References 23 publications
7
71
0
1
Order By: Relevance
“…Infusing AMPA into the NAcc produces enhanced locomotion in rats exposed to cocaine 2-3 weeks earlier (Bell and Kalivas, 1996;Pierce et al, 1996a) and AMPA receptor antagonists prevent the expression of locomotor sensitization by amphetamine (Karler et al, 1991;Tzschentke and Schmidt, 1997;Mead and Stephens, 1998;cf, Li et al, 1997) and cocaine (Pierce et al, 1996a;Jackson et al, 1998;Bell et al, 2000;cf, Karler et al, 1994;Li et al, 1997). The present results are consistent with these findings and extend them to the reinstatement of drug seeking.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Infusing AMPA into the NAcc produces enhanced locomotion in rats exposed to cocaine 2-3 weeks earlier (Bell and Kalivas, 1996;Pierce et al, 1996a) and AMPA receptor antagonists prevent the expression of locomotor sensitization by amphetamine (Karler et al, 1991;Tzschentke and Schmidt, 1997;Mead and Stephens, 1998;cf, Li et al, 1997) and cocaine (Pierce et al, 1996a;Jackson et al, 1998;Bell et al, 2000;cf, Karler et al, 1994;Li et al, 1997). The present results are consistent with these findings and extend them to the reinstatement of drug seeking.…”
Section: Discussionsupporting
confidence: 87%
“…For example, infusions of AMPA into the NAcc produce enhanced locomotion in animals exposed to cocaine 2-3 weeks earlier (Bell and Kalivas, 1996;Pierce et al, 1996a) and AMPA receptor antagonists administered systemically (Karler et al, 1991;Tzschentke and Schmidt, 1997;Jackson et al, 1998;Mead and Stephens, 1998;cf, Karler et al, 1994;Li et al, 1997) or into the NAcc (Pierce et al, 1996a;Bell et al, 2000) prevent the expression of locomotor sensitization by amphetamine (AMPH) and cocaine. When taken in light of the above findings and others showing that sensitization enhances the pursuit and self-administration of drugs (Vezina, 2004), these results suggest that previous exposure to psychostimulants should enhance the ability of NAcc AMPA to reinstate drug seeking.…”
Section: Introductionmentioning
confidence: 99%
“…The systemic administration of either NMDA (Karler et al, 1989;Wolf et al, 1995) or AMPA/kainate (Karler et al, 1991a;Li et al, 1997;cf Akiyama et al, 1998) receptor antagonists as well as the application into the VTA of either NMDA (Cador et al, 1999;Vezina and Queen, 2000) or mGlu (Kim and Vezina, 1998) receptor antagonists has been shown to prevent the induction of AMPH-induced locomotor sensitization. Moreover, systemically administering NMDA receptor antagonists with AMPH during preexposure also prevents cellular correlates of locomotor Figure 6 Injection cannula tip placements in the VTA.…”
Section: Induction Of Sensitization By Amph Requires Activation Of Glmentioning
confidence: 99%
“…Indeed, induction of locomotor sensitization by AMPH has been shown to be dependent on activation of Nmethyl-D-aspartate (NMDA: Cador et al, 1999;Vezina and Queen, 2000) and metabotropic glutamate (mGlu: Kim and Vezina, 1998) receptors in the VTA. Systemic administration of NMDA (Karler et al, 1989;Wolf et al, 1995) or a-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA)/kainate receptor antagonists (Karler et al, 1991a;Li et al, 1997) also prevents the development of locomotor sensitization by systemic AMPH. Moreover, induction of locomotor sensitization by AMPH is blocked by lesions of the PFC, which provides major glutamatergic afferentation to the VTA Cador et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…A glutamate-DA interaction is an important dynamic in the expression of behavioral sensitization in the NAS. Glutamate increases the release of DA in the NAS (Kalivas 1995;Kalivas & Stewart 1991), and motor activity elicited by injection of either DA or glutamate agonists into the NAS is diminished by coadministration of antagonists to the other neurotransmitter (Bell & Kalivas 1996;Kalivas 1995;Karler et al 1991;. NAS neurons also show enhanced responsiveness to glutamate in sensitized states that may be related to glutamate receptor adaptations observed in the NAS (Lu et al 1997;Nestler & Aghajanian 1997;Pierce et al 1996a;Zhang et al 1997).…”
Section: Experience-dependent Processesmentioning
confidence: 99%